| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/26/2008 | US20080153745 Compositions of tRNA and uses thereof |
| 06/26/2008 | US20080153132 recombinant ecarin protein that specifically activates prothrombin, being efficiently prepared by the genetic engineering technique; ecarin capable of serving conversion from prethrombin-2 to alpha -thrombin or from prothrombin to meizothrombin via cleavage at the Arg-Ile site |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153130 Ubp1 Protease Mutant and Its Coding Sequence, Their Applications and Heterogonous Protein Expression System |
| 06/26/2008 | US20080153129 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide) |
| 06/26/2008 | US20080153128 Amplifying a DNA molecule encoding the protein to prepare linear DNA molecules with a stem and loop sequence at their terminus; contacting amplified DNA molecules to a lysate of cells ( escherichia coli) with deficient endoribonuclease E activity to produce protein in the cell-free synthesis system |
| 06/26/2008 | US20080153126 Mutant Aox1 Promoters |
| 06/26/2008 | US20080152653 Heterodimeric integral membrane glycoprotein specific monoclonal antibody for use in treatment of cancer, inflammatory and/or autoimmune disease |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935981A1 Process for producing recombinant protein |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1934364A2 Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
| 06/25/2008 | EP1933877A2 Method of preparing a hydrogel |
| 06/25/2008 | EP1933873A2 Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 06/25/2008 | EP1861507A4 Optimization of heterologous polypeptide expression |
| 06/25/2008 | EP1463755B1 Recombinant polypeptides |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1179594B1 Ribonucleoprotein complex in paramyxovirus |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208424A Wood-rotting basidiomycetes for production of ligninolytic enzymes |
| 06/25/2008 | CN101205553A Method for preparing recombinant glossy ganoderma immunomodulatory protein |
| 06/25/2008 | CN101205530A Method for high-effectively expressing recombinant protein by employing animal cell fed-batch culture mode |
| 06/25/2008 | CN101204577A Process for preparing crystal composite of BTX-A |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 06/25/2008 | CN100396699C Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 06/25/2008 | CN100396697C New mastocancer related protein and its specificity multiclone antibody |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390887 Antibodies against PRO4330 |
| 06/24/2008 | US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 06/24/2008 | US7390879 Conjugation/biochemical; fibroblast growth factors |
| 06/24/2008 | US7390878 PRO6090 polypeptides |
| 06/24/2008 | US7390877 Vectors with DNA encoding pro polypeptides |
| 06/24/2008 | US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390661 Transcription activation module comprising nucleotide sequence; vectors for genetic engineering in plants |
| 06/24/2008 | US7390653 Apparatus for propagation of cells/tissues and generation of preferential proteins; bioreactors |
| 06/24/2008 | US7390651 has a reduced doubling time; for the production, expression and recovery of harvestable polypeptides, drug screening for metabolic activity, studying enteric disease and for use in a bio-artificial liver device |
| 06/24/2008 | US7390646 Bacterial vectors and methods of use thereof |
| 06/24/2008 | US7390643 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
| 06/24/2008 | US7390639 Purified nucleic acid sequence encoding a fusion protein comprising target peptide linked to a fusion carrier protein; carrier protein acts to promote the overexpression of peptide-protein fusion in the form of inclusion bodies, which minimizes in-cell proteolysis of peptides; nuclear magnetic resonance |
| 06/24/2008 | US7390637 Keratinocyte derived interferon |
| 06/24/2008 | US7390636 Method for construction and use of Kluyveromyces lactis promoter variants in K. lactis that substantially lack E. coli transcriptional capability |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390630 Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes |
| 06/24/2008 | US7390624 For immunoglobulin detection; for diagnosis of human immunodeficiency virus and hepatitis virus; solid phase synthesis |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/24/2008 | US7390403 Prefilter system for biological systems |
| 06/19/2008 | WO2008073688A2 Improved expression system for recombinant human arginase i |
| 06/19/2008 | WO2008073620A2 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| 06/19/2008 | WO2008073348A2 Microgravity bioreactor systems for production of bioactive compounds and biological macromolecules |
| 06/19/2008 | WO2008073184A2 Genetic incorporation of unnatural amino acids into proteins in mammalian cells |
| 06/19/2008 | WO2008072723A1 ANTI-Claudin-3 MONOCLONAL ANTIBODY, AND TREATMENT AND DIAGNOSIS OF CANCER USING THE SAME |
| 06/19/2008 | WO2008072547A1 Promoter and expression vector for actinomycetes |
| 06/19/2008 | WO2008043777B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 06/19/2008 | WO2007139846A3 Bacterial expression of phosphorylated hsp20 and reagents therefor |
| 06/19/2008 | WO2007127335A3 Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways |
| 06/19/2008 | WO2007121100A3 Compositions and methods for producing fermentation products and residuals |
| 06/19/2008 | WO2007109321A3 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 06/19/2008 | US20080146785 Antibody against tumor specific antigen as target |
| 06/19/2008 | US20080146508 Soluble cyclic analogues of beta amyloid peptide |
| 06/19/2008 | US20080146505 47 Human Secreted Proteins |
| 06/19/2008 | US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 06/19/2008 | US20080146492 Insulin production methods and pro-insulin constructs |
| 06/19/2008 | US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 06/19/2008 | US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 06/19/2008 | US20080145913 Endonuclease which reasserts mutations between related polynucleotides via formation of heteroduplex molecules and then addressing mismatches |
| 06/19/2008 | US20080145897 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, Isolated PEF protein, and methods for purifying and identifying |
| 06/19/2008 | US20080145896 Anti Hiv-I Bacterial and Baculovirus Recombinant Epap-1 |
| 06/19/2008 | US20080145895 Expression vector comprising nucleotide sequences coding light and heavy chain immunoglobulin segments for use as efficient gene transfer element in genetic engineering and gene therapy |
| 06/19/2008 | US20080145894 Methods and Materials for Expression of a Recombinant Protein |
| 06/19/2008 | US20080145893 Using chineese hamster ovaries as bioreactors for biosynthesis of immunoglobulin lihgt and heavy chains |
| 06/19/2008 | US20080145892 Expression vector comprising DBV gene cluster for use in transformation and synthesis of preferential peptide antibiotic |
| 06/19/2008 | US20080145872 Expression of HLA proteins on non human cells |
| 06/19/2008 | US20080145866 Modified human thymic stromal lymphopoietin |
| 06/19/2008 | US20080145861 Methods of protein production in cell lines |
| 06/19/2008 | US20080145377 G-CSF Polypeptides And Uses Thereof |
| 06/19/2008 | US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents |
| 06/19/2008 | US20080145365 Human and mammalian stem cell-derived neuron survival factors |
| 06/19/2008 | US20080145362 Antibody combination useful for tumor therapy |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | US20080145347 p-Hyde sequences in the Rat |
| 06/19/2008 | CA2823383A1 Method of producing protein from biomass |
| 06/19/2008 | CA2823244A1 Methods of processing biomass comprising electron-beam radiation |
| 06/19/2008 | CA2672581A1 Anti-claudin 3 monoclonal antibody and treatment and diagnosis of cancer using the same |
| 06/19/2008 | CA2671971A1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 06/19/2008 | CA2667502A1 Methods for improving antibody production |